Argonaut recommend buy with valuation of 42 cps. Forecast revenue of $120m and EPS of 4cps so a PE of 5.8 in FY 19, with positive cash flow in both half years in FY19.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025